Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Fonseca PCA"'
Autor:
Charles Swanton, Assaf Kacen, Aleksandra A. Kolodziejczyk, Matthias P. Kramer, Ina Koch, Michael Lindner, Stacher-Priehse E, Cohen Ij, Silke Meiners, Yifat Merbl, Aaron Javitt, Hila Wolf-Levy, Nir Friedman, Michal Alon, Yardena Samuels, Avital Eisenberg-Lerner, Shmueli, Radomir L, Elizabeta Bab-Dinitz, Oranit Zadok, Neiens, Ana Toste Rêgo, Yishai Levin, Adi Ulman, Iris Kamer, Eran Elinav, Jair Bar, da Fonseca Pca, Kevin Litchfield
SummaryProtein degradation by proteasomes is important for the immune response against tumors. Antigens generated by the proteasome promote immune cell infiltration into tumors and improve tumors’ responses to immunotherapy. For example, immunoprot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d786dd3d01be39253a760d3002979d
https://doi.org/10.1101/2021.10.24.464690
https://doi.org/10.1101/2021.10.24.464690
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Deni I; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Stokes BH; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Ward KE; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Fairhurst KJ; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Pasaje CFA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Yeo T; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Akbar S; School of Molecular Biosciences, University of Glasgow, Glasgow, Scotland, UK., Park H; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Muir R; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Bick DS; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Zhan W; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Zhang H; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Liu YJ; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Ng CL; Global Center for Health Security, University of Nebraska Medical Center, Omaha, NE, USA; Department of Biology, University of Nebraska Omaha, Omaha, NE, USA; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Kirkman LA; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY., Almaliti J; Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Jordan, Amman, Jordan., Gould AE; Takeda Development Center Americas, Inc., Cambridge, MA 02139, USA., Duffey M; Medicines for Malaria Venture, Geneva, Switzerland., O'Donoghue AJ; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Uhlemann AC; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Niles JC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., da Fonseca PCA; School of Molecular Biosciences, University of Glasgow, Glasgow, Scotland, UK., Gerwick WH; Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA., Lin G; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA., Bogyo M; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Fidock DA; Center for Malaria Therapeutics and Antimicrobial Resistance and Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: df2260@cumc.columbia.edu.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2023 May 18; Vol. 30 (5), pp. 470-485.e6. Date of Electronic Publication: 2023 Mar 23.
Autor:
Javitt A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Shmueli MD; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. merav.shmueli@weizmann.ac.il., Kramer MP; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Kolodziejczyk AA; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Cohen IJ; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Radomir L; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Sheban D; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Kamer I; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Litchfield K; UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bab-Dinitz E; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Zadok O; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel., Neiens V; Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum Muenchen, Munich, Germany.; Member of the German Center for Lung Research (DZL), Munich, Germany., Ulman A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Wolf-Levy H; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Eisenberg-Lerner A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Kacen A; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Alon M; Department of Molecular and Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Rêgo AT; MRC Laboratory of Molecular Biology, Cambridge, UK., Stacher-Priehse E; Asklepios Lung Clinic Munich-Gauting, Gauting, Germany., Lindner M; Asklepios Lung Clinic Munich-Gauting, Gauting, Germany., Koch I; Member of the German Center for Lung Research (DZL), Munich, Germany.; Asklepios Lung Clinic Munich-Gauting, Gauting, Germany., Bar J; Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Swanton C; UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Samuels Y; Member of the German Center for Lung Research (DZL), Munich, Germany., Levin Y; de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., da Fonseca PCA; Department of Molecular and Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; School of Molecular Biosciences, University of Glasgow, Glasgow, UK., Elinav E; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.; Division of Cancer-Microbiome Research, DKFZ, Heidelberg, Germany., Friedman N; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel., Meiners S; Comprehensive Pneumology Center (CPC), University Hospital, Ludwig-Maximilians University, Helmholtz Zentrum Muenchen, Munich, Germany.; Member of the German Center for Lung Research (DZL), Munich, Germany.; Research Center Borstel, Borstel, Germany.; Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, Germany.; Institute of Experimental Medicine, Christian-Albrechts University Kiel, Kiel, Germany., Merbl Y; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. Yifat.merbl@weizmann.ac.il.
Publikováno v:
Nature cancer [Nat Cancer] 2023 May; Vol. 4 (5), pp. 629-647. Date of Electronic Publication: 2023 May 22.
Autor:
Dubiel D; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany. Electronic address: dawaadschargal.dubiel@med.ovgu.de., da Fonseca PCA; School of Molecular Biosciences, University of Glasgow, Glasgow, UK. Electronic address: Paula.daFonseca@glasgow.ac.uk., Valášek LS; Laboratory of Regulation of Gene Expression, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: valasekl@biomed.cas.cz., Schulze-Niemand E; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany. Electronic address: eric.schulze-niemand@med.ovgu.de., Naumann M; Institute of Experimental Internal Medicine, Otto von Guericke University, Magdeburg, Germany. Electronic address: naumann@med.ovgu.de.
Publikováno v:
Biochimica et biophysica acta. Molecular cell research [Biochim Biophys Acta Mol Cell Res] 2023 Feb; Vol. 1870 (2), pp. 119402. Date of Electronic Publication: 2022 Nov 22.
Autor:
Živković D; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Sanchez Dafun A; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Menneteau T; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Schahl A; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Lise S; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Kervarrec C; Institut de Recherche en Santé, Environnement et Travail, INSERM, École des Hautes Études en Santé Publique (EHESP), Université de Rennes, UMR_S 1085, Rennes, 35042 France.; Protim, Université de Rennes, 35042 Rennes, France., Toste Rêgo A; Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom., da Fonseca PCA; Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom., Chavent M; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Pineau C; Institut de Recherche en Santé, Environnement et Travail, INSERM, École des Hautes Études en Santé Publique (EHESP), Université de Rennes, UMR_S 1085, Rennes, 35042 France.; Protim, Université de Rennes, 35042 Rennes, France., Burlet-Schiltz O; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Marcoux J; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France., Bousquet MP; Institut de Pharmacologie et de Biologie Structurale, CNRS, Université Paul Sabatier (UPS), Université de Toulouse, Toulouse, 31000 France.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Apr 12; Vol. 119 (15), pp. e2116826119. Date of Electronic Publication: 2022 Apr 04.
Autor:
Morris EP; Institute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow, UK.; Division of Structural Biology, The Institute of Cancer Research, London, UK., da Fonseca PCA; Institute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow, UK. paula.dafonseca@glasgow.ac.uk.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2021 May; Vol. 28 (5), pp. 409-410.